Meeting
2015 ASCO Annual Meeting
Pre-diabetes and breast cancer outcomes: Abrogating the confounding effect of anti-diabetic therapy.
Authors
Varinder Kaur
University of Arkansas for Medical Sciences, Little Rock, AR
Varinder Kaur , Ahmad Mazen Safar , Eric R Siegel , Jousheghany Fariba , Srikanth Medarametla , Thomas Kieber-Emmons , Karbassi Monzavi Behjatolah
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Genetics, and Epidemiology
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Etiology/Epidemiology
Citation
J Clin Oncol 33, 2015 (suppl; abstr 1584)
DOI
10.1200/jco.2015.33.15_suppl.1584
Abstract #
1584
Poster Bd #
408
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Does metformin use effect overall survival for patients with pancreatic cancer?
First Author: Ravi Ramjeesingh
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Salvage hepatic artery infusion chemotherapy after first-line systemic failure in patients with unresectable cholangiocarcinoma.
First Author: Naaz Nasar
Poster
2023 ASCO Annual Meeting
Associations between body mass index with cancer recurrence and all-cause mortality among survivors of breast cancer.
First Author: Po-Hua Chen
Poster
2023 ASCO Annual Meeting
Influence of adherence to adjuvant endocrine therapy in early breast cancer: Results from a large German real-world claims data analysis.
First Author: Dominik Dannehl